Safety and Efficacy of Cannabidiol for Grade I/II Acute Graft Versus Host Disease (GVHD) After Allogeneic Stem Cell Transplantation
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Graft Versus Host Disease
Related studies linked through entity extraction aliases.
Pharmacokinetics-based Mycophenolate Mofetil Dosing for GVHD Prevention
- Status
- COMPLETED
- Phase
- PHASE2
Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host Disease
- Status
- TERMINATED
- Phase
- PHASE2
Outcomes of Cutaneous T-Cell Lymphoma and Graft-Versus-Host Disease With Extracorporeal Photopheresis Treatment
- Status
- COMPLETED
- Phase
- N/A
In-vivo Regulatory T Cell Enhancement With Cyclophosphamide and Sirolimus
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Cannabidiol for Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
- Status
- COMPLETED
- Phase
- PHASE2
Extension Study (Extended Access) of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans
- Status
- COMPLETED
- Phase
- PHASE2
Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological Cancers
- Status
- UNKNOWN
- Phase
- PHASE2
Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer
- Status
- COMPLETED
- Phase
- NA
Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Pilot Study: Patients With Chronic Active Graft Versus Host Disease That Have Failed or Not Tolerated Standard Therapy.
- Status
- COMPLETED
- Phase
- N/A
Study of First Line Treatment of Chronic Graft Versus Host Disease With the Association of Ciclosporine, Corticosteroids and Rituximab (Protocol R-GVHD)
- Status
- COMPLETED
- Phase
- PHASE2
Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Rituximab Combined With Prednisone for the Initial Treatment of Chronic Graft Versus Host Disease (cGVHD)
- Status
- TERMINATED
- Phase
- PHASE2
Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
T-Lymphocyte Infusion or Standard Therapy in Treating Patients at Risk of Cytomegalovirus Infection After a Donor Stem Cell Transplant
- Status
- UNKNOWN
- Phase
- PHASE2
Safety and Efficacy Study of Allogenic Mesenchymal Stem Cells to Treat Extensive Chronic Graft Versus Host Disease
- Status
- UNKNOWN
- Phase
- PHASE2